{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:40:07Z","timestamp":1748479207631,"version":"3.41.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009558","name":"University Natural Science Research Project of Anhui Province","doi-asserted-by":"publisher","award":["2023AH050813"],"award-info":[{"award-number":["2023AH050813"]}],"id":[{"id":"10.13039\/501100009558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.cca.2025.120375","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T22:34:05Z","timestamp":1747521245000},"page":"120375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Sclerostin in ankylosing spondylitis: A meta-analysis"],"prefix":"10.1016","volume":"575","author":[{"given":"Li-Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Ling","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai-Xin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Gui","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Mei","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120375_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing spondylitis: etiology, pathogenesis, and treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res."},{"key":"10.1016\/j.cca.2025.120375_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.996103","article-title":"Joint together: The etiology and pathogenesis of ankylosing spondylitis","volume":"13","author":"Xiong","year":"2022","journal-title":"Front. Immunol."},{"issue":"15\u201316","key":"10.1016\/j.cca.2025.120375_b0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1089\/ten.tea.2020.0228","article-title":"Modulation of sost gene expression under hypoxia in three-dimensional scaffold-free osteocytic tissue","volume":"27","author":"Kim","year":"2021","journal-title":"Tissue Eng. A"},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.cca.2025.120375_b0025","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1111\/jcmm.15084","article-title":"Reduction of SOST gene promotes bone formation through the Wnt\/beta-catenin signalling pathway and compensates particle-induced osteolysis","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"19","key":"10.1016\/j.cca.2025.120375_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196248","article-title":"The role of sclerostin in rheumatic diseases: a review","volume":"12","author":"Jaskiewicz","year":"2023","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/s41467-022-28394-6","article-title":"Author correction: sclerostin inhibits Wnt signaling through tandem interaction with two LRP6 ectodomains","volume":"13","author":"Kim","year":"2022","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.cca.2025.120375_b0040","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10067-014-2663-6","article-title":"Wnt signaling in ankylosing spondylitis","volume":"33","author":"Corr","year":"2014","journal-title":"Clin. Rheumatol."},{"issue":"11","key":"10.1016\/j.cca.2025.120375_b0045","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.cca.2025.120375_b0050","first-page":"275","volume":"15","author":"Wakhlu","year":"2020","journal-title":"Prevalence of Low Bone Mineral Density in Ankylosing Spondylitis, Correlation with Disease Activity, and Serum Sclerostin Levels"},{"issue":"10","key":"10.1016\/j.cca.2025.120375_b0055","doi-asserted-by":"crossref","first-page":"688","DOI":"10.6061\/clinics\/2014(10)07","article-title":"Fetuin-A is related to syndesmophytes in patients with ankylosing spondylitis: a case control study","volume":"69","author":"Tuylu","year":"2014","journal-title":"Clinics (Sao Paulo)"},{"issue":"3","key":"10.1016\/j.cca.2025.120375_b0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jbspin.2016.05.008","article-title":"Serum levels of Dkk-1, sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking, and clinical, inflammatory and radiographic parameters","volume":"84","author":"Sakellariou","year":"2017","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.cca.2025.120375_b0065","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat. Methods Med. Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0070","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/jep.13159","article-title":"Comparison of four heterogeneity measures for meta-analysis","volume":"26","author":"Lin","year":"2020","journal-title":"J. Eval. Clin. Pract."},{"issue":"5","key":"10.1016\/j.cca.2025.120375_b0075","doi-asserted-by":"crossref","first-page":"R216","DOI":"10.1186\/ar4055","article-title":"Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?","volume":"14","author":"Saad","year":"2012","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.cca.2025.120375_b0080","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2474-13-191","article-title":"Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis","volume":"13","author":"Taylan","year":"2012","journal-title":"BMC Musculoskelet. Disord."},{"issue":"7","key":"10.1016\/j.cca.2025.120375_b0085","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3899\/jrheum.131199","article-title":"Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis","volume":"41","author":"Klingberg","year":"2014","journal-title":"J. Rheumatol."},{"issue":"17","key":"10.1016\/j.cca.2025.120375_b0090","first-page":"1300","article-title":"Correlation between sclerostin level and radiographic changes in patients with ankylosing spondylitis","volume":"95","author":"Xie","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.cca.2025.120375_b0095","unstructured":"C. Zhi-Yong, W. Song-Hua, Z. Guo-Tai, D.O.J.W.L.M.I. Orthopedics, The relationship between serum ossification factor and m SASSS score in Ankylosing Spondylitis patients, (2015)."},{"issue":"5","key":"10.1016\/j.cca.2025.120375_b0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00223-015-0093-3","article-title":"Higher level of dickkopf-1 is associated with low bone mineral density and higher prevalence of vertebral fractures in patients with ankylosing spondylitis","volume":"98","author":"Rossini","year":"2016","journal-title":"Calcif. Tissue Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12891-017-1425-4","article-title":"Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS, DISH, OPLL, and OYL","volume":"18","author":"Niu","year":"2017","journal-title":"BMC Musculoskelet. Disord."},{"issue":"08","key":"10.1016\/j.cca.2025.120375_b0110","first-page":"1394","article-title":"Correlation analysis between serum osteocalcin levels and bone imaging changes in patients with ankylosing spondylitis","volume":"19","author":"Tian","year":"2017","journal-title":"Zhejiang Clin. Med."},{"issue":"2","key":"10.1016\/j.cca.2025.120375_b0115","first-page":"302","article-title":"Implication of osteoprotegerin and sclerostin in axial spondyloarthritis cardiovascular disease: study of 163 Spanish patients","volume":"36","author":"Genre","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.cca.2025.120375_b0120","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9101964","article-title":"Serum sclerostin as a possible biomarker in ankylosing spondylitis: a case-control study","volume":"2018","author":"Perrotta","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"4","key":"10.1016\/j.cca.2025.120375_b0125","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10067-018-4356-z","article-title":"Sclerostin rather than Dickkopf-1 is associated with mSASSS but not with disease activity score in patients with ankylosing spondylitis","volume":"38","author":"Sun","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.cca.2025.120375_b0130","doi-asserted-by":"crossref","unstructured":"N.M.A.E.S. Sakrana, N.M.E. Badr, M.A.A. Hassan, M.A.K. Hassan, Serum sclerostin as a biomarker of disease activity in ankylosing spondylitis in correlation with radiographic imaging, Egyptian Rheumatology and Rehabilitation, 51(1) (2024), p. 25, 10.1186\/s43166-024-00 258 -5.","DOI":"10.1186\/s43166-024-00258-5"},{"key":"10.1016\/j.cca.2025.120375_b0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1471-2474-14-99","article-title":"High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damage","volume":"14","author":"Korkosz","year":"2013","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.cca.2025.120375_b0140","volume":"39","author":"Ustun","year":"2014","journal-title":"Sclerostin and Dkk-1 in Patients with Ankylosing Spondylitis"},{"issue":"32","key":"10.1016\/j.cca.2025.120375_b0145","first-page":"5085","volume":"21","author":"Lu","year":"2017","journal-title":"Serum Levels of Dickkopf-1, Sclerostin and Vascular Endothelial Growth Factor A and Their Correlation with Ankylosing Spondylitis Progression"},{"issue":"5","key":"10.1016\/j.cca.2025.120375_b0150","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00296-019-04298-5","article-title":"Evaluation of serum fibroblast growth factor-23 in patients with axial spondyloarthritis and its association with sclerostin, inflammation, and spinal damage","volume":"39","author":"Gercik","year":"2019","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0155","article-title":"Anti-tumor necrosis factor alpha treatment does not influence serum levels of the markers associated with radiographic progression in ankylosing spondylitis","volume":"38","author":"Ozdemirel","year":"2023","journal-title":"Arch. Rheumatol."},{"issue":"5","key":"10.1016\/j.cca.2025.120375_b0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3899\/jrheum.170833","article-title":"Sclerostin and antisclerostin antibody serum levels predict the presence of axial spondyloarthritis in patients with inflammatory bowel disease","volume":"45","author":"Luchetti","year":"2018","journal-title":"J. Rheumatol."},{"issue":"2","key":"10.1016\/j.cca.2025.120375_b0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00198-022-06523-7","article-title":"Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders","volume":"34","author":"Marini","year":"2023","journal-title":"Osteoporos Int."},{"issue":"23","key":"10.1016\/j.cca.2025.120375_b0170","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.cca.2025.120375_b0175","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2004.05.023","article-title":"Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation","volume":"35","author":"Sutherland","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.cca.2025.120375_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2022.116636","article-title":"Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density","volume":"167","author":"O'Donohue","year":"2023","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11882-014-0489-6","article-title":"Update on ankylosing spondylitis: current concepts in pathogenesis","volume":"15","author":"Smith","year":"2015","journal-title":"Curr. Allergy Asthma Rep."},{"issue":"10","key":"10.1016\/j.cca.2025.120375_b0190","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/nutrit\/nuad010","article-title":"Prevalence of vitamin D deficiency in South America: a systematic review and meta-analysis","volume":"81","author":"Mendes","year":"2023","journal-title":"Nutr. Rev."},{"issue":"7","key":"10.1016\/j.cca.2025.120375_b0195","first-page":"603","article-title":"Vitamin D deficiency and insufficiency in Africa and the Middle East, despite year-round sunny days","volume":"105","author":"Green","year":"2015","journal-title":"S. Afr. Med. J."},{"issue":"3","key":"10.1016\/j.cca.2025.120375_b0200","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.numecd.2016.11.005","article-title":"Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels","volume":"27","author":"Torino","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"12","key":"10.1016\/j.cca.2025.120375_b0205","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00296-020-04708-z","article-title":"Bone turnover biomarkers, disease activity, and MRI changes of sacroiliac joints in patients with spondyloarthritis","volume":"40","author":"Iaremenko","year":"2020","journal-title":"Rheumatol. Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120375_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00223-019-00542-z","article-title":"Serum sclerostin and bone morphogenetic protein-2 levels in patients with ankylosing spondylitis: a meta-analysis","volume":"105","author":"Xu","year":"2019","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.cca.2025.120375_b0215","doi-asserted-by":"crossref","unstructured":"G. Nocturne, S. Pavy, S. Boudaoud, R. Seror, P. Goupille, P. Chanson, D. van der Heijde, F. van Gaalen, F. Berenbaum, X. Mariette, K. Briot, A. Feydy, P. Claudepierre, P. Dieude, J. Nithitham, K.E. Taylor, L.A. Criswell, M. Dougados, C. Roux, C. Miceli-Richard, Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort, PLoS One, 10(8) (2015) e0134974, 10.1371\/journal.pone.0134974.","DOI":"10.1371\/journal.pone.0134974"},{"issue":"3","key":"10.1016\/j.cca.2025.120375_b0220","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/rheumatology\/key128","article-title":"Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis","volume":"58","author":"van der Heijde","year":"2019","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.cca.2025.120375_b0225","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00223-015-0105-3","article-title":"How accurate is your sclerostin measurement? Comparison between three commercially available sclerostin ELISA kits","volume":"98","author":"Piec","year":"2016","journal-title":"Calcif. Tissue Int."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125002542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:17:05Z","timestamp":1748477825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125002542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"alternative-id":["S0009898125002542"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120375","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sclerostin in ankylosing spondylitis: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120375","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120375"}}